Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

Comparison of Whole-Body PET/CT, Dedicated High-Resolution Head and Neck PET/CT, and Contrast-Enhanced CT in Preoperative Staging of Clinically M0 Squamous Cell Carcinoma of the Head and Neck

Rosana S. Rodrigues, Fernando A. Bozza, Paul E. Christian, John M. Hoffman, Regan I. Butterfield, Carl R. Christensen, Marta Heilbrun, Richard H. Wiggins, Jason P. Hunt, Brandon G. Bentz, Ying J. Hitchcock and Kathryn A. Morton
Journal of Nuclear Medicine August 2009, 50 (8) 1205-1213; DOI: https://doi.org/10.2967/jnumed.109.062075
Rosana S. Rodrigues
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando A. Bozza
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul E. Christian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John M. Hoffman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Regan I. Butterfield
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl R. Christensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Heilbrun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard H. Wiggins III
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason P. Hunt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brandon G. Bentz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying J. Hitchcock
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn A. Morton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    Site of infection or inflammation may mimic primary tumor by PET/CT. HN PET/CT shows false-positive lesion due to peridontal abscess (solid arrow). Primary tumor was actually small skin lesion that was missed by all imaging modalities.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Change in SUVmax from WB to HN protocol for primary tumor.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    ROC analyses of CECT, WB PET/CT, and HN PET/CT protocols in detection of nodal metastases by level and by patient. Dotted line = CECT; dashed line = WB; solid line = HN.

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    SUVmax in WB and HN protocols for positive and negative nodes. Dotted black line is placed just above highest SUVmax for negative nodes. Red line shows median of SUVmax for each group.

  • FIGURE 5. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5. 

    PET/CT had difficulty in distinguishing reactive from malignant nodes. HN PET/CT protocol shows primary tumor (curved arrow), true-positive left level II node (open arrow), and false-positive right level II node (solid arrow). Both lymph nodes were similar in metabolic activity.

  • FIGURE 6. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6. 

    Change in SUVmax from WB PET/CT protocol (90 min after injection) to HN PET/CT protocol (150 min after injection) for positive and negative nodes.

  • FIGURE 7. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7. 

    Three examples in which HN PET/CT protocol (upper panel) detected small (<15 mm) histologically proven positive lymph nodes that were missed by standard WB protocol (lower panel). Arrows indicate discordant nodes.

Tables

  • Figures
    • View popup
    TABLE 1

    Acquisition and Processing Parameters for WB PET/CT and High-Resolution, Contrast-Enhanced HN PET/CT (Siemens Biograph PET/CT)

    ParameterWB PET/CTHN PET/CT
    Technique CTkVp, 120; mA, 240kVp, 120; mA, 200
    CT collimation (mm)1.50.75
    Bed time (min)612
    Matrix (PET image)168256, with 1.5 zoom
    Pixel size (mm)4.161.82
    Filter FWHM (mm)5 (7 if >78.75 kg)2.0
    Iteration46
    Subset814
    Intravenous contrastNoYes
    Interval from injection (min)90150
    BedCradleFlat
    Head positionIn head holderIn head holder (chin up)
    • FWHM = full width at half maximum.

    • View popup
    TABLE 2

    Distribution of Primary Tumor Location

    Primary tumor sitesNumber of patientsTotal (%)
    Oropharyngeal2966
    Hypopharyngeal12
    Laryngeal49
    Skin49
    Unknown primary site614
    Total44100
    • View popup
    TABLE 3

    Detection of Primary Tumor by CECT, WB, and HN Protocols

    Imaging studySensitivity (%)Specificity (%)Accuracy (%)PPV (%)NPV (%)
    CECT7167709327
    WB PET/CT protocol*921009310067
    HN PET/CT protocol†9583939771
    • ↵* P = 0.0357, when compared with CECT.

    • ↵† P = 0.0125, when compared with CECT.

    • View popup
    TABLE 4

    Detection of Nodal Metastases per Level by CECT Parameters

    CECT featureSensitivity (%)Specificity (%)PPV (%)NPV (%)Accuracy (%)
    Size (enlarged)6389668879
    Shape (round)8366459273
    Contrast enhancement (any)8368479274
    Heterogeneous enhancement6396848983
    Absence of fatty hilum9721299551
    Necrosis5398908681
    Extracapsular spread4398888477
    Asymmetry100213010052
    Overall CT appearance5788638681
    • Total number of nodal levels evaluated by CECT alone was 77. Prevalence of malignant nodal levels was 25.27%. PPV = positive predictive value; NPV = negative predictive value.

    • View popup
    TABLE 5

    ROC Analysis for Detection of Nodal Metastases by CECT, WB PET/CT, and HN PET/CT Protocols

    ParameterBy levelBy patient
    Area under the curve
     CECT0.7220.863
     WB protocol0.7900.850
     HN protocol0.8960.936
    95% confidence interval
     CECT0.623–0.8200.741–0.984
     WB protocol0.699–0.8810.730–0.970
     HN protocol0.836–0.9560.860–1.000
    Comparison of CT vs. WB PET/CT
     Difference between areas0.0690.0125
     Significance levelP = 0.099P = 0.0811
    Comparison of CT vs. HN PET/CT
     Difference between areas0.1740.074
     Significance levelP < 0.001P = 0.152
    Comparison of WB vs HN PET/CT
     Difference between areas0.1060.086
     Significance levelP < 0.002P = 0.059
    • View popup
    TABLE 6

    Change in SUVmax from WB to HN Protocol for Positive and Negative Nodes

    Change in SUVmaxPositive node*Negative node*
    Increase ≥ 10%23 (71.87)42 (84.00)
    Increase 0%−10%3 (09.38)5 (10.00)
    Decrease6 (18.75)3 (06.00)
    Number of nodes32 (100.00)50 (100.00)
    • ↵* Data are number of nodes, with percentages in parentheses.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 50 (8)
Journal of Nuclear Medicine
Vol. 50, Issue 8
August 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Whole-Body PET/CT, Dedicated High-Resolution Head and Neck PET/CT, and Contrast-Enhanced CT in Preoperative Staging of Clinically M0 Squamous Cell Carcinoma of the Head and Neck
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of Whole-Body PET/CT, Dedicated High-Resolution Head and Neck PET/CT, and Contrast-Enhanced CT in Preoperative Staging of Clinically M0 Squamous Cell Carcinoma of the Head and Neck
Rosana S. Rodrigues, Fernando A. Bozza, Paul E. Christian, John M. Hoffman, Regan I. Butterfield, Carl R. Christensen, Marta Heilbrun, Richard H. Wiggins, Jason P. Hunt, Brandon G. Bentz, Ying J. Hitchcock, Kathryn A. Morton
Journal of Nuclear Medicine Aug 2009, 50 (8) 1205-1213; DOI: 10.2967/jnumed.109.062075

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of Whole-Body PET/CT, Dedicated High-Resolution Head and Neck PET/CT, and Contrast-Enhanced CT in Preoperative Staging of Clinically M0 Squamous Cell Carcinoma of the Head and Neck
Rosana S. Rodrigues, Fernando A. Bozza, Paul E. Christian, John M. Hoffman, Regan I. Butterfield, Carl R. Christensen, Marta Heilbrun, Richard H. Wiggins, Jason P. Hunt, Brandon G. Bentz, Ying J. Hitchcock, Kathryn A. Morton
Journal of Nuclear Medicine Aug 2009, 50 (8) 1205-1213; DOI: 10.2967/jnumed.109.062075
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Effect of Time-of-Flight Technique on the Diagnostic Performance of 18F-FDG PET/CT for Assessment of Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma
  • Negative Predictive Value of Surveillance PET/CT in Head and Neck Squamous Cell Cancer
  • Positron Emission Tomography With [18F]Fluorodeoxyglucose Improves Staging and Patient Management in Patients With Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Study
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire